Molecular Docking and Virtual Screening
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
13
Treatment against Mutation of PIK3CA Gene Involved in Lung Cancer by Structure Base Pharmacophore Modeling, Virtual Screening and Molecular Docking
14
Investigation of Phosphodiesterase 5A (PDE5A) Inhibitors by Pharmacophore Modeling, Virtual Screening and Molecular Docking Approach
6
Virtual Screening and Molecular Docking for Arylalkylamine N Acetyltransferase (aaNAT) Inhibitors, a Key Enzyme of Aedes (Stegomyia) aegypti (L ) Metabolism
10
Structure-based virtual screening and molecular docking for the identification of potential multi-targeted inhibitors against breast cancer
13
Virtual Screening of Natural Products, Molecular Docking and Dynamics Simulations on M.tuberculosis S-adenosyl-L-homocysteine Hydrolase
7
DESIGNING POTENT ANTITRYPANOSOMAL AGENTS USING 3D QSAR, PHARMACOPHORE MODELLING, VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES
15
Virtual screening and molecular docking of Anti-Antileishmanial for selected pharmacophore for visceral Leishmaniasis
6
“Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for the Discovery of Novel CDK2 Inhibitors” by H. Abdulghani, F. Sliman, Syria.
9
IDENTIFICATION OF POTENT VIRTUAL LEADS AS TOPOISOMERASE II INHIBITORS USING PHARMACOPHORE MODELLING, MOLECULAR DOCKING AND ADME STUDIES
16
Virtual Screening and Molecular Docking of 4,6,7 Tri Substituted Quinazoline Derivatives as Potential EGFR Inhibitors
21
VIRTUAL SCREENING AND MOLECULAR DOCKING OF NDM1 INHIBITOR FOR TREATMENT OF KLEBSIELLA PNEUMONIA INFECTION
8
Simeprevir, potential candidate to repurpose for coronavirus infection: Virtual screening and molecular docking study
12
Calculating an optimal box size for ligand docking and virtual screening against experimental and predicted binding pockets
10
Molecular modeling studies of HIV-1 non-nucleoside reverse transcriptase inhibitors using 3D-QSAR, virtual screening and docking simulations
14
Virtual screening of natural and synthetic inhibitors of cyclooxygenase COX-2 enzyme using docking-scoring functions
8
VIRTUAL SCREENING OF INDONESIAN HERBAL DATABASE TO FIND SIRTUIN 1 ACTIVATORS USING THE DOCKING METHOD
5
3D Pharmacophore-based Virtual Screening, Docking Approaches toward the Discovery of Novel HPPD Inhibitors
14
IVSPlat 1.0: an integrated virtual screening platform with a molecular graphical interface
10
Exploring Structural Parameters for Designing Cox 1 and Cox 2 Inhibitors: Pharmacophoric Modeling, Virtual Screening and Docking Study
7